Gene of the month: BAP1
- PMID: 27235536
- DOI: 10.1136/jclinpath-2016-203866
Gene of the month: BAP1
Abstract
The BAP1 gene (BRCA1-associated protein 1) is a tumour suppressor gene that encodes a deubiquitinating enzyme (DUB), regulating key cellular pathways, including cell cycle, cellular differentiation, transcription and DNA damage response. Germline BAP1 mutations cause a novel cancer syndrome characterised by early onset of multiple atypical Spitz tumours and increased risk of uveal and cutaneous melanoma, mesothelioma, renal cell carcinoma and various other malignancies. Recognising the clinicopathological features of specific BAP1-deficient tumours is crucial for early screening/tumour detection, with significant impact on patient outcome.
Keywords: CANCER GENETICS; MELANOMA; RENAL CANCER.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Tumours associated with BAP1 mutations.Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Pathology. 2013. PMID: 23277170 Review.
-
BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.Hum Pathol. 2015 Feb;46(2):239-45. doi: 10.1016/j.humpath.2014.10.015. Epub 2014 Nov 4. Hum Pathol. 2015. PMID: 25479927
-
Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.J Cutan Pathol. 2015 Jun;42(6):406-12. doi: 10.1111/cup.12493. Epub 2015 May 12. J Cutan Pathol. 2015. PMID: 25902915
-
BAP1-deficient and VE1-negative atypical Spitz tumor.J Cutan Pathol. 2015 Aug;42(8):564-7. doi: 10.1111/cup.12519. Epub 2015 Jun 12. J Cutan Pathol. 2015. PMID: 25953246
-
BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.J Cutan Pathol. 2019 Dec;46(12):965-972. doi: 10.1111/cup.13530. Epub 2019 Jul 11. J Cutan Pathol. 2019. PMID: 31233225 Review.
Cited by
-
Current Management and Future Perspective in Pleural Mesothelioma.Cancers (Basel). 2022 Feb 18;14(4):1044. doi: 10.3390/cancers14041044. Cancers (Basel). 2022. PMID: 35205798 Free PMC article. Review.
-
Identification, genetic testing, and management of hereditary melanoma.Cancer Metastasis Rev. 2017 Mar;36(1):77-90. doi: 10.1007/s10555-017-9661-5. Cancer Metastasis Rev. 2017. PMID: 28283772 Free PMC article.
-
Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations.Endocr Pathol. 2019 Dec;30(4):276-284. doi: 10.1007/s12022-019-09595-0. Endocr Pathol. 2019. PMID: 31734934
-
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome.Breast Cancer. 2022 Sep;29(5):921-927. doi: 10.1007/s12282-022-01354-0. Epub 2022 Apr 5. Breast Cancer. 2022. PMID: 35381901 Free PMC article.
-
Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers.Eur Urol Open Sci. 2021 Jan 9;24:52-59. doi: 10.1016/j.euros.2020.12.007. eCollection 2021 Feb. Eur Urol Open Sci. 2021. PMID: 34337496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
